Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies is a research paper published in BMJ (2023). On theSindex it has a DataRank of 0.817. It has been cited 231 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.817
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →FWCI
49.33
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies
Additional file 1 of Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022–2023 (CAMS-22)
Additional file 1 of Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022–2023 (CAMS-22)
Additional file 1 of “I don’t need my kid to be high”: prioritizing harm reduction when using cannabis during pregnancy
Additional file 1 of “I don’t need my kid to be high”: prioritizing harm reduction when using cannabis during pregnancy
Additional file 2 of “I don’t need my kid to be high”: prioritizing harm reduction when using cannabis during pregnancy
Additional file 2 of “I don’t need my kid to be high”: prioritizing harm reduction when using cannabis during pregnancy